◀ Back to NOS1
NOS1 — ZGLP1
Text-mined interactions from Literome
Salehi et al., PloS one 2008
(Diabetes Mellitus, Experimental...) :
The incretin hormone
GLP-1 , which is used in clinical practice
suppressed iNOS and
ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release
Chai et al., Diabetes 2012
:
After confirming that
GLP-1 potently
stimulates nitric oxide ( NO ) synthase ( NOS ) phosphorylation in endothelial cells, overnight fasted adult male rats received continuous GLP-1 infusion ( 30 pmol/kg/min ) for 2 h plus or minus NOS inhibition
Zheng et al., Cardiovascular diabetology 2013
(Diabetes Mellitus, Type 2) :
Twenty-four weeks of acarbose monotherapy in newly diagnosed patients with T2D is associated with significantly increased levels of both fasting and postprandial
GLP-1 as well as significantly
increased NO levels and
NOS activity for those patients in whom postprandial GLP-1 levels were increased